| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Physiology and Biophysics, The University of Iowa College of Medicine, Iowa City, Iowa 52242
Address all correspondence and requests for reprints to: Deborah L. Segaloff, Ph.D., Department of Physiology and Biophysics, The University of Iowa College of Medicine, Iowa City, Iowa 52240.
The lutropin/choriogonadotropin receptor (LHR) is a G protein-coupled receptor central to reproductive physiology. In addition to the complex structure formed by seven membrane-spanning helices, this receptor also contains a large amino-terminal domain whose tertiary structure is unknown. Many mutations of this receptor result in partial or complete intracellular retention of the mutant, regardless of whether the mutations are located in the extracellular domain, interhelical loops, transmembrane helices, or cytoplasmic tail. Nonetheless, as long as a mutation has not disturbed a hormone binding site, the intracellularly trapped mutant retains high affinity binding for human CG (hCG), suggesting that it is not extremely misfolded. Because temperature is known to affect protein folding, we examined the effects of reduced temperature on cell surface expression of intracellularly retained mutants of the LHR. Our studies examined three different 293 cells lines, each stably expressing a different LHR mutant that is intracellularly retained at 37 C. The results presented demonstrate that preincubation of the cells for 48 h at 26 C markedly increased both the total hCG binding activity within each cell line as well as the percentage of binding activity at the cell surface. Furthermore, the cells bound hCG with a normal high affinity and responded to hCG with increased cAMP production normally. These data suggest that decreased temperatures can allow partially misfolded LHRs to fold properly and be expressed in functional form on the cell surface and thus present the potential for utilization of this approach for other intracellularly retained G protein-coupled receptor mutants.
This article has been cited by other articles:
![]() |
N. V. Bogatcheva, A. Ferlin, S. Feng, A. Truong, L. Gianesello, C. Foresta, and A. I. Agoulnik T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E138 - E144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mizrachi and D. L. Segaloff Intracellularly Located Misfolded Glycoprotein Hormone Receptors Associate with Different Chaperone Proteins than Their Cognate Wild-Type Receptors Mol. Endocrinol., July 1, 2004; 18(7): 1768 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Tao, N. B. Johnson, and D. L. Segaloff Constitutive and Agonist-dependent Self-association of the Cell Surface Human Lutropin Receptor J. Biol. Chem., February 13, 2004; 279(7): 5904 - 5914. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tan, H. H. Nickols, and L. E. Limbird Appropriate Polarization following Pharmacological Rescue of V2 Vasopressin Receptors Encoded by X-linked Nephrogenic Diabetes Insipidus Alleles Involves a Conformation of the Receptor That Also Attains Mature Glycosylation J. Biol. Chem., September 12, 2003; 278(37): 35678 - 35686. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kubiak, M. J. Larsen, S. C. Nulf, M. R. Zantello, K. J. Burton, J. W. Bowman, T. Modric, and D. E. Lowery Differential Activation of "Social" and "Solitary" Variants of the Caenorhabditis elegans G Protein-coupled Receptor NPR-1 by Its Cognate Ligand AF9 J. Biol. Chem., September 5, 2003; 278(36): 33724 - 33729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirakawa, C. Galet, and M. Ascoli MA-10 Cells Transfected with the Human Lutropin/Choriogonadotropin Receptor (hLHR): A Novel Experimental Paradigm to Study the Functional Properties of the hLHR Endocrinology, March 1, 2002; 143(3): 1026 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. Petaja-Repo, M. Hogue, A. Laperriere, P. Walker, and M. Bouvier Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human delta Opioid Receptor J. Biol. Chem., April 28, 2000; 275(18): 13727 - 13736. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Rozell, D. P. Davis, Y. Chai, and D. L. Segaloff Association of Gonadotropin Receptor Precursors with the Protein Folding Chaperone Calnexin Endocrinology, April 1, 1998; 139(4): 1588 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Latronico, Y. Chai, I. J.P. Arnhold, X. Liu, B. B. Mendonca, and D. L. Segaloff A Homozygous Microdeletion in Helix 7 of the Luteinizing Hormone Receptor Associated with Familial Testicular and Ovarian Resistance Is Due to Both Decreased Cell Surface Expression and Impaired Effector Activation by the Cell Surface Receptor Mol. Endocrinol., March 1, 1998; 12(3): 442 - 450. [Abstract] [Full Text] |
||||
![]() |
P. L. Durham, R. V. Sharma, and A. F. Russo Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1 Receptor Activation J. Neurosci., December 15, 1997; 17(24): 9545 - 9553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |